Literature DB >> 31662549

Primary Hemangiopericytoma Arising in Extralobar Pulmonary Sequestration: A Coincidence or Two Rare Disorders?

Christos F Kampolis1, Christos Damaskos2, Angeliki A Loukeri3, Nikolaos Garmpis4, Anna Garmpi5, Ioannis Tomos6, Eleftherios Spartalis7, Dimitrios Dimitroulis4, Alexandros Patsouras8, Marousa Douskou9, Spyros A Papiris6, Periklis Tomos10.   

Abstract

BACKGROUND/AIM: Extralobar pulmonary sequestration (EPS) is an unusual congenital defect characterized by the presence of non-functioning lung tissue receiving arterial supply from the systemic arteries. Primary hemangiopericytoma (HPC) is an uncommon potentially malignant tumor of vascular origin that usually involves the soft tissue of the extremities or retroperitoneum, but extremely rarely affects the lung. We present the rare case of a primary pulmonary HPC arising in an EPS. CASE REPORT: A 65-year-old woman, with dyspnea and pleuritic chest pain, was referred for further investigation. Radiological evaluation demonstrated a well-circumscribed mass above the right hemidiaphragm, receiving its arterial supply from the descending thoracic aorta. The patient underwent a right posterolateral thoracotomy and a middle lobectomy. The intraoperative finding was a well-encapsulated solid mass. The histological evaluation described HPC.
RESULTS: The patient remains fit and healthy.
CONCLUSION: Pulmonary HPC can arise in EPS. Surgical excision is the treatment of choice. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Hemangiopericytoma; extralobar; pulmonary; sequestration

Mesh:

Substances:

Year:  2019        PMID: 31662549      PMCID: PMC6899116          DOI: 10.21873/invivo.11715

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  18 in total

1.  Primary hemangiopericytoma of lung: radiography and pathology.

Authors:  M S Shin; K J Ho
Journal:  AJR Am J Roentgenol       Date:  1979-12       Impact factor: 3.959

Review 2.  Imaging of pulmonary sequestration.

Authors:  R E Felker; I L Tonkin
Journal:  AJR Am J Roentgenol       Date:  1990-02       Impact factor: 3.959

3.  HEMANGIOPERICYTOMA: A VASCULAR TUMOR FEATURING ZIMMERMANN'S PERICYTES.

Authors:  A P Stout; M R Murray
Journal:  Ann Surg       Date:  1942-07       Impact factor: 12.969

4.  Extralobar pulmonary sequestration as a cause of recurrent pulmonary hemorrhage in a neonate.

Authors:  Arzu Akdag; Sule Arici; Mete Kaya; Ahmet Turgut
Journal:  Arch Argent Pediatr       Date:  2016-02       Impact factor: 0.635

5.  Lung sequestration: report of seven cases and review of 540 published cases.

Authors:  B Savic; F J Birtel; W Tholen; H D Funke; R Knoche
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

6.  Primary pulmonary hemangiopericytoma.

Authors:  S A Yousem; L Hochholzer
Journal:  Cancer       Date:  1987-02-01       Impact factor: 6.860

7.  Pulmonary congenital cystic disease in adults. Spiral computed tomography findings with pathologic correlation and management.

Authors:  M Scialpi; S Cappabianca; A Rotondo; G B Scalera; F Barberini; L Cagini; S Donato; L Brunese; I Piscioli; L Lupattelli
Journal:  Radiol Med       Date:  2010-01-07       Impact factor: 3.469

8.  Assessment of 64-row computed tomographic angiography for diagnosis and pretreatment planning in pulmonary sequestration.

Authors:  Jian-Zhuang Ren; Kai Zhang; Guo-Hao Huang; Meng-Fan Zhang; Peng-Li Zhou; Xin-Wei Han; Xu-Hua Duan; Zhen Li
Journal:  Radiol Med       Date:  2013-11-15       Impact factor: 3.469

9.  CT and MR features of primary pulmonary hemangiopericytomas.

Authors:  M Halle; U Blum; E Dinkel; W Brugger
Journal:  J Comput Assist Tomogr       Date:  1993 Jan-Feb       Impact factor: 1.826

10.  Massive pulmonary hemangiopericytoma. An innovative approach to evaluation and treatment.

Authors:  V W Rusch; W P Shuman; R Schmidt; G E Laramore
Journal:  Cancer       Date:  1989-11-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.